Mundipharma
Ian Minors is an experienced IT professional currently serving as the Head of Business Intelligence at Mundipharma IT Services since December 2011, where responsibilities include managing the Applications, Middleware, Business Intelligence and Innovation team to design and maintain superior IT and BI solutions. Prior roles at Mundipharma include Head of Applications and Infrastructure Delivery and Applications Services Manager, focusing on application development and support functions. Ian's earlier experience consists of positions as Lead Software Engineer at Napp Pharmaceuticals from 2008 to 2011 and as a Software Engineer from 2001 to 2008, alongside a role as Systems Engineer at Bristol Babcock from 1997 to 2001, working on SCADA and DCS projects. Ian holds an MSc in Mechatronics and a BSc Hons in Physics from Lancaster University, attended from 1991 to 1996.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.